Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TL vs AL Bismuth Quadruple Therapy for H. pylori
NCT03779087Completed
- Start
- Jul 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tetracycline, amoxicillin and levofloxacin in Helicobacter pylori infection (2 arms). Primary endpoint: Number of Participants in Which H. Pylori Was Eradicated at 6 weeks. Started Jul 2018; status: completed.
02
Drugs
tetracyclineamoxicillinlevofloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03779087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03779087.